Takahiro Sakamoto
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 17, 2020
The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum.Hiroki Ishibashi, Morikazu Miyamoto, Hiroshi Shinmoto
|May 30, 2020
Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.Soichiro Kakimoto, Morikazu Miyamoto, Takahiro Einama
|Apr 13, 2020
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.Hiroaki Soyama, Morikazu Miyamoto, Hiroko Matsuura
|Mar 04, 2018
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano
|Nov 24, 2017
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.Hiroaki Soyama, Morikazu Miyamoto, Masashi Takano
|Nov 11, 2017
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.Morikazu Miyamoto, Masashi Takano, Mika Kuwahara
Pageof 1
Frequent Collaborators
6 joint publications
Morikazu Miyamoto
6 joint publications
Masashi Takano
5 joint publications
Hideki Iwahashi
4 joint publications
Hiroaki Soyama
4 joint publications
Hiroko Matuura
4 joint publications
Hiroki Ishibashi
3 joint publications
Mika Kuwahara
3 joint publications
Kento Kato
3 joint publications
Kazuki Takasaki
3 joint publications
Tadashi Aoyama
